Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nina Zolotarjova is active.

Publication


Featured researches published by Nina Zolotarjova.


Methods of Molecular Biology | 2008

Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum.

James Martosella; Nina Zolotarjova

Serum analysis represents an extreme challenge because of the dynamic range of the proteins of interest, and the high structural complexity of the constituent proteins. High-abundant proteins such as albumin, IgG, transferrin, haptoglobin, IgA and alpha1-anti-trypsin represent up to 85% of the total protein mass in serum (Fig. 1). These major protein constituents interfere with identification and characterization of important moderate- and low-abundant proteins by limiting the dynamic range of mass spectral and electrophoretic analysis. During protein isolation, separation, and analysis, these six proteins often mask the detection of the more important low-abundant proteins that are of high interest as biomarkers of disease or drug targets. In one- and two-dimensional gel electrophoresis (1DGE and 2DGE) for example, the spots or bands because of these six highly abundant proteins, as well as their fragments, often overlap or completely mask large regions of the gel, making detection of the myriad low-abundant proteins very difficult, if not impossible. Moreover, proteomic analysis methods commonly include an electrophoretic or chromatographic separation step which, of course, has a finite mass loading tolerance. The presence of a large quantity of high-abundant proteins limits the mass load of targeted proteins that can be initially sampled by these separation methods and thus requires the need for multidimensional separation techniques to reduce sample complexity. Fig. 1 Composition of proteins in human serum. The protein composition is schematically depicted based on mass abundance in normal human serum. The six high-abundant proteins removed by the immunoaffinity column comprise approx 85% of the total protein mass in human serum. Herein we describe immunoaffinity depletion combined with reversed-phase separation modes to reduce the sample complexity of human serum. We selectively immunodepleted six of the most abundant proteins from human serum, then employed gradient elution reversed-phase (RP) HPLC to fractionate the remaining serum proteins. The workflow shown in (Fig. 2) was optimized to process immunodepleted flow-through serum samples directly to a RP column with minimal sample handling. The RP operational conditions permitted robust and repeatable separations and have been optimized specifically for immunodepleted serum samples.


Proteomics | 2005

Differences among techniques for high-abundant protein depletion.

Nina Zolotarjova; James Martosella; Gordon R. Nicol; Jerome Bailey; Barry E. Boyes; William C. Barrett


Journal of Proteome Research | 2005

Reversed-Phase High-Performance Liquid Chromatographic Prefractionation of Immunodepleted Human Serum Proteins to Enhance Mass Spectrometry Identification of Lower-Abundant Proteins

James Martosella; Nina Zolotarjova; Hongbin Liu; Gordon R. Nicol; Barry E. Boyes


Electrophoresis | 2004

Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry

Giuseppina Maccarrone; Dale Milfay; Isabel Birg; Marcus C. Rosenhagen; Florian Holsboer; Rudolf Grimm; Jerome Bailey; Nina Zolotarjova; Christoph W. Turck


Journal of Chromatography A | 2008

Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum

Nina Zolotarjova; Peter Mrozinski; Haiying Chen; James Martosella


Journal of Proteome Research | 2006

High Recovery HPLC Separation of Lipid Rafts for Membrane Proteome Analysis

James Martosella; Nina Zolotarjova; Hongbin Liu; Susanne C. Moyer; Patrick D. Perkins; Barry E. Boyes


Archive | 2004

Methods, systems and devices for performing analytical protocols

Barry E. Boyes; Nina Zolotarjova; Gordon R. Nicol


Archive | 2006

Methods and systems for on-column protein delipidation

James Martosella; Nina Zolotarjova


PharmaGenomics | 2004

Enhancing analytical access to low-abundant proteins in the human plasma proteome

Cory Szafranski; Jerome Bailey; Christoph W. Turck; Gordon R. Nicol; James Martosella; Nina Zolotarjova


Cancer Research | 2006

A novel approach for the identification of HeLa membrane proteins by combining reversed-phase protein pre-fractionation with Nano-chip-LC/MS

James Martosella; Hongbin Liu; Nina Zolotarjova; Susanne Moyer; Peter Mrozinski; Rhonda Taylor; Jerome Bailey

Collaboration


Dive into the Nina Zolotarjova's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge